会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NUCLEIC ACID AMPLIFICATION WITH INTEGRATED MULTIPLEX DETECTION
    • 具有集成多重检测的核酸扩增
    • WO2006028987A2
    • 2006-03-16
    • PCT/US2005031357
    • 2005-09-02
    • BIOARRAY SOLUTIONS LTDSEUL MICHAELKORZHEVA NATALIYAYANG JIACHENGZHANG YI
    • SEUL MICHAELKORZHEVA NATALIYAYANG JIACHENGZHANG YI
    • C12Q1/68
    • C12Q1/6865C12Q2563/149C12Q2563/107C12Q2537/143
    • A method mediated with in-vitro transcription ("IVT") which permits miniaturization of multiplexed DNA and RN analysis, and in which elongation-mediated multiplexed analysis of polymorphisms (eMAP®) is used as the analysis step, is described. Also described is a method mediated with IVT is for selecting a designated strand from T7­-tagged double a stranded DNA: wherein, the selected strand forms the template for RNA synthesis. In one embodiment, double stranded DNA incorporating the T7 (or other) promoter sequence at the 3' end or the 5'end is produced, for example, by amplification of genomic DNA using the Polymerase Chain Reaction (PCR). Also disclosed are nested PCR designs permitting allele analysis in combination with strand selection by IVT. Further, in one embodiment of a homogeneous format for transcription-mediated amplification and multiplexed detection (which may be particularly suited for viral or pathogen detection), encoded microparticles display "looped" capture probe configurations permitting the generation of a signal upon capture of RNA product and real-time assay monitoring.
    • 描述了使用多体DNA和RN分析进行小型化的体外转录(“IVT”)介导的方法,其中使用延长介导的多态性复合分析(eMAP)作为分析步骤。 还描述了用IVT介导的用于从T7标记的双链DNA选择指定链的方法:其中所选择的链形成用于RNA合成的模板。 在一个实施方案中,例如通过使用聚合酶链反应(PCR)扩增基因组DNA来产生在3'末端或5'端掺入T7(或其它)启动子序列的双链DNA。 还公开了允许等位基因分析与IVT的链选择组合的巢式PCR设计。 此外,在用于转录介导的扩增和多重检测(其可能特别适用于病毒或病原体检测)的均匀形式的一个实施方案中,编码的微粒显示“循环”捕获探针构型,其允许在捕获RNA产物时产生信号 和实时测定监测。
    • 8. 发明申请
    • A TRANSFUSION REGISTRY AND EXCHANGE NETWORK
    • 转移注册和交换网络
    • WO2009064280A3
    • 2009-07-02
    • PCT/US2007072193
    • 2007-11-14
    • BIOARRAY SOLUTIONS LTDZHANG YISEUL MICHAEL
    • ZHANG YISEUL MICHAEL
    • A61B5/00
    • G06Q10/00G06Q50/22
    • Disclosed is a registry for candidate transfusion donors, which invokes an inventory management policy to create and actively manage lists of candidate donors in order to minimize imbalances between demand and supply across multiple regions and across multiple categories of donors and recipients. Together with a genotyping laboratory, the registry does targeted recruitment of prospective donors who are typed for a set of genetic markers relating to clinically relevant antigens including mutations of Human Erythrocyte Antigens (HEA), genetic variants of Rh, and possibly additional antigens such as HLA and HPA. The registry monitors incoming demand for transfusion antigen genotypes, preferably stratify the demand into a set of categories representing stable subpopulations, and will apply strategies, disclosed herein, to tune the composition of candidate donor lists to match the demand, thereby avoiding excess, and unnecessary, typing of candidate donors,
    • 公布了候选人输血捐助者的登记册,该登记处援引了库存管理政策,以创建和主动管理候选人捐助者名单,以便最大限度地减少多个地区和多个捐助者和接受者之间的需求与供应之间的不平衡。 与基因分型实验室一起,注册管理机构确实针对招募潜在的捐赠者,这些捐赠者是针对一系列与临床相关抗原相关的遗传标记,包括人类红细胞抗原(HEA)的突变,Rh的遗传变异体和可能的其他抗原如HLA 和HPA。 注册管理机监测输血抗原基因型的输入需求,最好将需求分为一组代表稳定亚群体的类别,并将应用本文所披露的策略来调整候选捐献者名单的组成以匹配需求,从而避免过多和不必要的 ,候选人的打字,
    • 9. 发明申请
    • A TRANSFUSION REGISTRY AND EXCHANGE NETWORK
    • 转移注册和交换网络
    • WO2008051630A3
    • 2008-10-30
    • PCT/US2007067420
    • 2007-04-25
    • BIOARRAY SOLUTIONS LTDZHANG YISEUL MICHAEL
    • ZHANG YISEUL MICHAEL
    • G06F19/00G06F17/00
    • G06F19/327G06Q30/02G06Q30/0202G06Q50/22G06Q50/24G16H40/20
    • Disclosed is a registry for candidate transfusion donors, which invokes an inventory management policy to create and actively manage lists of candidate donors in order to minimize imbalances between demand and supply across multiple regions and across multiple categories of donors and recipients. Together with a genotyping laboratory, the registry does targeted recruitment of prospective donors who are typed for a set of genetic markers relating to clinically relevant antigens including mutations of Human Erythrocyte Antigens (HEA), genetic variants of Rh, and possibly additional antigens such as HLA and HPA. The registry monitors incoming demand for transfusion antigen genotypes, preferably stratify the demand into a set of categories representing stable subpopulations, and will apply strategies, disclosed herein, to tune the composition of candidate donor lists to match the demand, thereby avoiding excess, and unnecessary, typing of candidate donors.
    • 公布了候选人输血捐助者的登记册,该登记处援引了库存管理政策,以创建和主动管理候选人捐助者名单,以便最大限度地减少多个地区和多个捐助者和接受者之间的需求与供应之间的不平衡。 与基因分型实验室一起,注册管理机构确实针对招募潜在的捐赠者,这些捐赠者是针对一系列与临床相关抗原相关的遗传标记,包括人类红细胞抗原(HEA)的突变,Rh的遗传变异体和可能的其他抗原如HLA 和HPA。 注册管理机监测输血抗原基因型的输入需求,最好将需求分为一组代表稳定亚群体的类别,并将应用本文所披露的策略来调整候选捐献者名单的组成以匹配需求,从而避免过多和不必要的 ,候选人捐款人的打字。